Article
CYP2A6 genetic polymorphism is associated with decreased susceptibility to squamous cell lung cancer in Japanese smokers.
Drug metabolism and pharmacokinetics - 1 Aug 2015
Hosono Hiroki, Kumondai Masaki, Arai Tomio, Sugimura Haruhiko, Sasaki Takamitsu, Hirasawa Noriyasu, Hiratsuka Masahiro
Abstract excerpt
Cytochrome P450 2A6 (CYP2A6) is an enzyme involved in the metabolism of tobacco carcinogens, which are important risk factors in lung cancer. We and others have previously reported that CYP2A6*4, a whole-gene deletion polymorphism, is associated with lower risk of lung cancer than the wild-type allele. However, the genotyping method used in these previous studies considered only the CYP2A6*4 allele; this lead to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
